UAB Ritamum pharma Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,140,177 |
| 228,035 |
| 366,068 |
| 310,559 |
| 62,112 |
| 68.99 |
| 27.24 |
| 466,950 |
| 115,426 |
| 17,860 |
| 563,985 |
| 2024 |
|---|
| 1,168,280 |
| 232,725 |
| 444,618 |
| 376,364 |
| 74,973 |
| 60.71 |
| 32.22 |
| 566,844 |
| 114,884 |
| 13,134 |
| 667,934 |
| 2025 |
|---|
| 1,219,650 |
| 255,157 |
| 446,467 |
| 375,020 |
| 78,456 |
| 61.89 |
| 30.75 |
| 603,040 |
| 185,286 |
| 102,077 |
| 684,183 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 1,219,650 |
| 255,157 |
| 446,467 |
| 375,020 |
| 78,456 |
| 61.89 |
| 30.75 |
| 603,040 |
| 185,286 |
| 102,077 |
| 684,183 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
1,219,650 €4 % *
Sales per employee (€)
255,157 €10 % *
Profit before tax (€)
446,467 €0 % *
Net Profit (€)
375,020 €0 % *
Profit per employee (€)
78,456 €5 % *
Total profitability (%)
61.89 %1.94 % *
Net profitability (%)
30.75 %-4.56 % *
Equity (€)
603,040 €6 % *
Amounts Payable And Liabilities (€)
185,286 €61 % *
Non-current Assets (€)
102,077 €677 % *
CurrentAssets (€)
684,183 €2 % *
